Law360, New York (April 10, 2012, 6:58 PM ET) -- The U.S. Food and Drug Administration has concluded birth control pills containing drospirenone may be associated with a higher risk of blood clots, and will include information from recent studies examining that risk to labels for drugs containing the hormone, the agency announced Tuesday.
The revised labels for the drugs, which include Bayer AG's Yaz and Yasmin, will report that some studies showed as much as a three-fold increase in the risk of blood clots for birth control pills containing drospirenone compared with products containing other...
FDA Adds Blood Clot Risk Data To Birth Control Labels
To view the full article, take a free trial now.
